Senescence of osteogenic cells. Review;Komórki osteogenne w przebiegu starzenia siȩ. Przegla̧d informacji

Ortopedia Traumatologia Rehabilitacja

Volumn 9, Issue 1, 2007, Pages 63-67

  Włodarski, Krzysztof H ^a   Włodarski, Paweł K ^a   Galus, Ryszard ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Ageing; Bone marrow; Osteoprogenitor cells

Indexed keywords

AGING; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; BONE TISSUE; CELL ACTIVITY; CELL PROLIFERATION; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; REVIEW; SENESCENCE; SENILITY; STEM CELL; STROMA CELL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; BONE MARROW; CELL AGING; FEMALE; HUMANS; MALE; MICE; OSTEOBLASTS; OSTEOGENESIS; STROMAL CELLS;

EID: 34249999210     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Srouji S, Livne E. Bone marrow stem cells and biological scaffold for bone repair in aging and disease. Mech Ageing Dev 2005; 126: 281-7.
2. Stenderup K, Rosada C, Justesen J, Al-Soubky T, Dagnaes-Hansen F, Kassem M. Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization. Biogerontology 2004; 5: 107-18.
3. Stenderup K, Justensen J, Eriksen EF, Rattan SI, Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and patients with osteoporosis. J Bone Miner Res 2001; 16: 1120-9.
4. Tanaka H, Ogasa H, Barnes J, Liang CT. Action of bFGF on mitogenic activity and lineage expression in rat osteoprogenitor cells: effect of age. Mol Cell Endocrinol 1999; 150: 1-10.
5. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 2002; 71: 36-44.
6. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33: 919-26.
7. Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001; 19: 117-25.
8. Laskela HV, Risteli J, Niskanen S, Koivunen J, Ivaska KK, Lehenkari P. Biochem Biophys Res Commun 2003; 311: 10083-13.
9. Bellows CG, Pei W, Jia Y, Heersche JN. Proliferation, differentiation and self-renewal of osteoprogenitors in vertebral cell populations from aged and young female rats. Mech Ageing Dev 2003; 124: 747-57.
10. Kveiborg M, Flyvbjerg A, Rattan SI, Kassem M. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions. Exp Gerontol 2000; 35: 1061-74.
11. Batge B, Feydt A, Gebken J i wsp. Age-related differences in the expression of receptors for TGF-beta in human osteoblast-like cells in vitro. Exp Clin Endocrinol Diabetes 2000; 108: 311-5.
12. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004; 22: 675-82.
13. Kveiborg M, Kassem M, Langdahl B, Eriksen EF, Clark BF, Rattan SI. Telomere shorteninf during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients. Mech Ageing Dev 1999; 106: 261-71.
14. Makhluf HA, Mueller SM, Mizuno S, Glowacki J. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. Biochem Biophys Res Commun 2000; 268: 669-72.
15. Włodarski KH, Włodarski P. Fuzja prekursorów osteoklastów oraz regulacja aktywnoości osteoklastów dojrzałych. Postȩpy Biologii Komórki 2006; 33: 273-284.
16. Cao J, Venton L, Sakata T, Halloran BP. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 2003; 18: 270-7.
17. Cao JJ, Wronski TJ, Iwaniec U i wsp. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res 2005; 20: 1659-68.
18. Lisignoli G, Piacentini A, Toneguzzi S I wsp. Age-associated changes in functional response to CXCR3 and CXCR5 chemokine receptors in human osteoblasts. Biogerontology 2003; 4: 309-17.
19. Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT. Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis [errata opublikowana w: J Biol Chem. 2003; 278: 45040]. J Biol Chem 2003; 278:32005-13.
20. Matsumoto A, Yamai K, Kawanami M, Kato H. Effect of aging on bone formation induced by recombinant human bone morphogenetic protein-2 combined with fibrous collagen membraned at subperiosteal sites. J Periodontal Res 2001; 36: 175-82.
21. Cui L, Ma YF, Yao W i wsp. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain. J Bone Miner Metab 2001; 19: 29-37.
22. Keila S, Kelner A, Weinreb M. Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J Endocrinol 2001; 168: 131-9.